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Abstract : Mucoepidermoid carcinoma (MEC) has been characterized by t (1; 19)(q21; 
p13). This chromosomal translocation has been recently shown to generate a MECT1-
MAML2 fusion gene. MEC can pose diagnostic challenges when they are of high-grade， 
of variant histologic appearanc巴 andoccurring in an unusual site. The aim of this study 
was to evaluate the frequency of the MECT1-MAML2 fusion gene among primary 
salivary gland MECs and extrasalivary gland MECs， together with some histological 
variants and its role as a possible diagnostic adjunct， comparing the salivary gland 
tumors including Warthin's tumor(WT)， pleomorphic adenoma(PA)， and adenoid cystic 
carcinoma(ACC). Using a reverse transcription】polymerase chain (RT-PCR)-based 
approach， we assayed for the MECT1-MAML2 transcript in 39 cases for which paraffin】
embedded tumor tissue with adequate RNA was available. These included 19 MECs， 10 
WTs， five PAs， and five ACCs. The MECT1-MAML2 fusion gene transcript was 
detected in 16 (84.2%) of 19 MECs. These positive cases included two cases of MEC with 
WT-like areas， a sclerosing MEC and a clear cel MEC. Three negative cases were high同
grade MECs. Two of them were not easy to distinguish from squamous cel carcinoma. 
The MECT1-MAML2 fusion gene was negative in al cases of WT， P A and ACC. The 
potential usefulness of MECT1-MAML2 fusion gene expression as a molecular marker in 
the diagnosis of MEC is supported. 
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INTRODUCTION 
Mucoepidermoid carcinoma (MEC) of the salivary glands represents 15.5% of al salivary 
gland tumors and 22 to 41% of the malignant forms1). Histologically， MEC is composed of 
mucous】secretingcells， epidermoid cells， and intermediate cells in variable combinations. It 
is classified into low-， intermediate-， and high-grade types on the basis of morphologic and 
cytologic features 1• 2). MEC occasionally displays morphologic variations with a minimum or 
complete absence of more typical morphologic features， which can present diagnostic 
difficulties1• 3). Among these features are a predominance of clear cells， a spindle cel】like
pattern of growth， sebaceous-like differentiation， a predominantly oncocytic app回 rance，areas 
mimicking Warthin's tumor (WT) and a sclerosing patternl-7). The differential diagnosis of 
low-grade MEC included pleomorphic adenoma (PA) with squamous metaplasia， cystadenoma 
and mucocele 3). The existence of high同gradeMEC and the relevance of its distinction from 
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poor1y differentiated adenocarcinoma or squamous cel carcinoma， have a1so been challenged1， 
3)， Therefore， itis desirab1e to identify a mo1ecu1ar marker that is sensitive and specific for 
MEC. 
To date， the karyotypic profi1einお1EChas been described in 30 cases8): innine cases there 
were rearrangements of 11q14-21 and 19p12-13， main1y as a chromosoma1 trans1ocation， t(l1 ; 
19) (q21 ; p12-13)9)， and this was the sole abnorma1ity in three cases9-1). The remaining 
sixcases showed either a more comp1巴xtrans1ocation invo1ving other chromosomes or other 
rearrangements8). The same abnormality has a1so been described in MEC originatingin 
bronchia1 glands of the 1ungll，12). Interesting1y， t(11;19)(q13-21;p12-13) was a1so reported in 
WTI3，l4) a benign sa1ivary gland neop1asm， which suggested an unexpected cytogenetic 
association between two otherwise unre1ated sa1ivary gland tumors. However， itis known 
that WT  can arise and/or co-exist with MEC， warranting a reappraisa1 of this association5，7). 
Thetrans1ocationt(11 ; 19) (q21; p13) found in MEC has recent1y been clonedI5). Two genes are 
invo1ved: the mucoepidermoid carcinoma trans10cated 1(MECT1) gene and a member of the 
mastermind-1ike gene fami1y (MAML2) 10cated at 19p13 and 11q21， respective1yI5). This 
trans1ocation generates a chimeric gene in which exon 1 of MECTlisfused with exons 2-5 of 
MAML2. This MECT1-MAML2 fusion product disrupts the Notch signaling pathway， 
activating Notch-target genes independent1y of exogenous signa1s， therefore representing a 
nove1 mechanism for a1tered Notch function in tumorigenesisl5)目 Inaddition， recent study of 
the MECT 1 gene product as a potent co-activator for gene responsive e1ements indicョtes
that MECT1-MAML2 may disrupt both the Notch and CREB signa1ing pathways to induce 
tumorigenesis1札 17) Recent1y， MECT1-MAML2 fusion gene expression has been studied in 
MEC， using a conventiona1 cytogenetic ana1ysis， RT-PCR with frozen tumor tissue and in situ 
hybridization (ISH)18). There are some reports about the detection of the MECT1-MAML2 
fusion gene by RT-PCR assay using paraffin-embedded tumor tissue. The corre1ation 
between the MECT1-MAML2 fusion gene and variants of MECs and the utility of this 
chimeric product as an ancillary diagnostic too1 have not been examined， 
Therefore， we used an RT-PCR assay for the MECT1-MAML2 transcript to exp10re the 
preva1ence of this fusion transcript in a series of 19 primary MECs， 10 primary WTs， five 
p1eomorphic adenoma(PA)s and five adenoid cystic carcinoma(ACC)s， using paraffin-
embedded tumor tissue. 
MATE阻 ALSAND METHODS 
Case selection 
All the previous1y diagnosed cases of mucoepidermoid carcinoma (MEC) ， Warthin's tumor 
(WT)， p1eomorphic adenoma (PA) and adenoid cystic carcinoma (ACC) in the fi1es of the 
Department of Diagnostic Patho1ogy， Nara Medica1 University， were rec1assified according to 
the Wor1d Hea1th Organization's criteriaI9). MEC cases were graded according to Goode and 
Ellis's criteria1，却 Allthe tumors examined were primary 1esions， associated with one 
metastatic 1esion (case 10B) and recurrence (case 19A'). All the tumors were fixed in 10% 
neutra1田bufferedforma1in. The oldest paraffin b10ck was processed in 1992 (case 10A). In 
sixteen cases specimens from sa1ivary glands and 1ungs were obtained from resected tumor 
specimens. The remaining three 1esions (10B， 18， 19)， obtained at curettage or open biopsi吋
MECT1-MAML2 fusion transcripts in mucoepidermoid carcinoma (71) 
Table la. Clinicopathologic features and RT-PCR Data from the Tumor Samples Collected 
RT-PCR 
Cas巴 Sex/Age Histo1ogic Diagnosis Location h但 CTl-MAML2 PGK 
32/F MEC LG N asopharynx + 十
2 56ぶf MEC LG Ora1 + + 
3 5l/F MEC LG Tonsil，抗 + + 
4 64/F 恥1EC LG WTLA Parotid， lt + + 
5 53/F MEC LG Sclerosing Ora1 十 十
6 75/F 乱1EC LG C1ear c巴1 Subrnandibu1ar，lt + 十
7 48/F MEC IG Sub1ingua1， rt 十 十
8 68ゐf MEC IG Subrnaxillary， lt + + 
9 76!F MEC IG Ora1 十 + 
10 A 70!F MEC IG LLL 十 + 
B Cerebe11urn， 1t 十 + 
1 68/F 恥1EC IG WTLA Parotid， rt + + 
12 68瓜f MEC HGJ Parotid，1t 十 + 
13 69ぶ4 MEC HG Maxillary sinus， rt 十 + 
14 63ぶf 恥1EC HG RLL ート + 
15 74!F MEC HG Subrnaxi11ary， lt 十 + 
16 49ゐf MEC HG Parotid， rt + + 
17 51瓜在 MEC HG Parotid， rt 十
18 67ゐf 恥1EC HG Maxillary sinus，rt + 
19 A 58ぶf MEC HG Nasal cavity，lt 十
A' N asal cavity，lt + 
MEC，Muco巳'pide口noidcarcinorna; LG; Low grade; IG， Intermediate grade; HG; High 
grade; A， Primary turnor; N， Loca1 recurrence turnor at 6 rnonth 1ater; BヲMetastatic
brain旬morat 3 years later; WTLA， W紅白in'sturnor-like ar巳a; RLL， Right lower 
lobe oflung; LLL， Left 10wer lobe. 
tumors， were examined. Each of the blocks contained over half of the tumor's area. Both in 
case 4 and in case 11， b10cks contained MEC (approximate1y 60%) and WT-like areas. 
Paraffin-embedded specimens of ten WTs， five PAs， and five ACCs were also included in this 
study. The clinical， histopathological， and RT同PCRdata are shown in Table 1. 
RNA Extraction 
Total RNA was extracted from the paraffin embedded tissues， according to a previously 
reported protoco1 with some modifications21• 22). In brief， 10-fllll-thick tissue sections were cut 
from each block and deparaffinized with two changes of xylene followed by three washes 
with 100% ethanol. Tissue fragments of each specimen were treated with a cocktail 
containing 10μL of proteinaseK(100mg/ml) and 200μL of lysis buffer (20mM Tris凶HCl(pH8.0)，
2伽nMEDTA and 2% sodium dodecyl sulfate) and incubated overnight at 550C until the 
sections were completely dissolv巴d.To optimize the extraction of RNA， the digested lysate of 
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each of which was solubilized in 1.0 ml of Trizol reagent (Gibco BRL， Gaithersburg， MD)， 
according to the manufacturer's directions. The precipitated RNA was then washed in 70% 
ethanol， redissolved in 10μL of DEPC-treated water (Invitrogen Life T巴chnologies，Carlsbad， 
CA)， treated with 1μL of DNAase 1 for 15 minutes at 3rc to eliminate contaminat巴dgenomic 
DNA， extracted again with 100μL of the Trizol reagent， and subsequently resolubilized in 
10μL of DEPC-treated water . 
RT困PCRAnalysis 
For the synthesis of the first-strand cDNA， 4μ1 of total RNA， 4μL of 25nM MgCI2， 2μL of 
10xPCR buffer (Applied Biosystems， Foster City， CA)， 1μL of 50μM random hexamers 
(Invitrogen)， 2μL of 10nM of dNTPmix (Invitorogen)， 20units of RNAase inhibitor 
(Invitorogen)， and 100 units of reverse transcriptase (Superscript I， Invitrogen) were added 
to a final reaction volume of 20μ:L. The RT reaction was performed at 420C for 40 minutes 
and then the mixture was heated at 700C to inactivate the revers巴 transcriptase.The 
oligonucleotide primer sets used for the paraffin-embedded tissue to amplify a segment from 
the MECT1-MAML2 cDNA starting in exon 1 from the MECT1 gene and finishing in exon 2 
from the MAML2 gene were sense MECT1-FWD (agatggcgacttcgaacaat) and antisense 
MAML2-REV (gctgttggcaggagataggt) with the expected PCR product size being 182-bp. 
PCR was performed in a final reaction volume of 50μL containing 2μL of RT product， 1.5mM 
of MgCb， 1xPCR buffer (Applied Biosystems)， O.lmM of dNTP mix， 0.5μ:M each of the sense 
and antisense primer and 0.5 units of Gold Taq DNA polymerase (Applied Biosystems) 
PCRs were performed for 40 cycles of amplification， using the following thermal cycle profile: 
950C for 45 seconds， 560C for 45 seconds and 72 oC for 1minute. After the last cycle， a final 
extension at 720C for 10 minutes was carried out and then the temperature was held at 40C. 
Negative controls for cDNA synthesis and PCRs， in which the template was replaced by 
sterile water， were included in each experiment. RNA integrity and efficiency of cDNA 
synthesis were confirmed in each sample by RT-PCR for the house四keeping gene 
phosphoglycerate kinase (PGK)， using previously published oligonucleotide primers231. 
Amplification with these primers yielded a 189四bpproduct. PCR products were analyzed and 
purified by electrophoresis in a 2% agarose gel stained with ethidium bromide. All the 
experiments were repeated， at least twice， with different batches of mRNA extracted at 
different times， from the same tumor. In the cases that presented the MECT1-MAML2 
rearrangement， the PCR product was sequenced (ABI Prism 377 DNA Sequencer， using the 
ABI Prism Big Dye Terminator Cycle Sequencing Ready Reaction Kit version1.l; Applied 
Biosystems， Foster City， USA). 
RESULTS 
Clinicopathological features 
Table 1 summarizes the salient clinical and pathologic information. The patients with 
MEC studied ranged in age from 32 to 76 years at first presentation (mean 61.0 years). Nine 
tumors were located in major salivary glands (parotid 5 cases， submaxillary 2 cases， 
submandibula ar 1 case) and two cases in the lungs. Seven cases seemed to involve minor 
salivary glands in oral and nasopharyngeal regions. 
The cases selected were reclassified as low-grade (n=6)， six intermediate田grade(6)， and 
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Tabl巴 lb.Clinicopathologic features and RT-PCR Data from the Tumors 
RT-PCR 
Case SexJAge Histo1ogic Diagnosis Location MECT1幽MAML2 PGK 
20 54瓜f WT Parotid，lt + 
21 64瓜4 WT Parotid， rt + 
22 63瓜f WT Parotid，lt + 
23 76瓜4 WT Parotid，lt 十
24 67瓜f WT Parotid， rt 十
25 48瓜4 WT Parotid，lt 十
26 75/M WT Parotid， 1t. 十
27 67/M WT Parotid，lt 十
28 53/M WT Parotid， rt 十
29 52/M WT Parotid， rt 十
30 54/M PA Parotid， rt. + 
31 70lF PA Parotid，lt 十
32 33/F PA Submandibu1ar， rt + 
33 53/F PA Parotid， rt + 
34 46/F PA Lower1ip + 
35 50lF ACC Extema1 ear， 1t + 
36 59ぶf ACC Submandibu1ar， rt 十
37 511M ACC RUL + 
38 67ぶ4 ACC Lower1ip + 
39 58/M ACC Ora1 cavity + 
WT， Warthin's旬mor;PA， P1eomorphic adenoma; ACC， Adenoid cystic carcinoma; RUL， 
Right upper 10be of1ung 
high-grade (7) MECs. Since adequate fol1ow目updata were not available， we couldn't evaluate 
the relation between the MECT1-MAML2 fusion gene expression and prognosis in this 
study. 
Two cases had conventional MEC areas (Case 4 : 10w grade， Casell : intermediate grade)， 
associated with WT-like areas composed of a glandular epithelial component with 
characteristic eosinophilic cytoplasm and a lymphoid stroma (Fig.1. A， B， C). In Case 5， the 
m句ority(approximately 70%) of the tumor was composed of a central paucicel1u1ar area of 
dense hyaline sc1erosis (Fig.l. D， E). One of the low戸gradeMEC (case 6) was composed of 
prominent c1ear cel1s (approximately 80%)， associated with a smal1 amount of intermediate 
and mucous cel1s (Fig.1， F). 
Detection of MECTI-MAML2 fusion gene by RT-PCR 
The results of RT-PCR are summarized in Table 1. We detected the MECT1-MAML2 
fusion transcript in 16 (84.2%) of 19 MECs (Fig. 2). Sequence analysis of the positive 
RT-PCR products confirmed the presence of the s釘 nerearrangement in the sixteen cases. 
Sixteen cases of MEC with positive RT-PCR products inc1uded variant histology， two cases 
of Warthin【1ikearea， one sc1erosing type， and one c1ear cel1 type. The MECT1-MAML2 
(74) T. Kasai， etal. 
Fig. 1. Variants of mucoepidermoid carcinoma 
A， B， C;Mucoepidermoid carcinoma (MEC) with Warthin's tumor (WT)ーlikearea (case 4)。
A) MEC (left side) showing solid growth and WT-like (right side) area showing cystic epithelial element 
with lymphoid stroma 
B) The cystic lesion lined double and multilayered with oncocytic cels surrounded by lymphoid stroma in 
the WT-like area 
C) MEC characterized by intermediate or squamous cels， and mucous cels. 
D， E: Sclerosing MEC (case 5) 
D) Sclerosing MEC displaying solid or trabecular tumor nests within marked sclerotic stroma 
E) The tumor nests showing intermediate and mucous cels with tubular formation 
F: Clear cel MEC with most of tumor cels showing a clear cytoplasm (case 6) 
fusion gene was detected in primary and metastatic lesions in Case 10. Sequencing analysis 
of the positive RT-PCR products confirmed the presence of the same arrangement in 16 
cases with the product of the fusion between MECT1 exon 1 and MAML2 exon 2. Otherwise， 
three negative cases of MEC were initialy diagnosed as high-grade. Two of them were 
indistinguishable from squamous cel carcinoma. There was no巴xpressionof the fusion 
gene either in ten羽TTs，in five PAs， or in five ACCs. The 189-bp RT-PCR product for the 
PGK housekeeping gene was detected in all 41 paraffin tumor blocks of 39 cases， indicating 
adequate sampling and confirming mRNA integrity (Fig. 2). 
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A)MECT1・MAML2
182・bp
B)PGK 
189・bp
Fig.2 
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MEC 明T/PA/ACC
RT-PCR detection of MECTl-MAML2 fusion gene transcript， using primers in MECTl exon l(sense) and 
MAML2 exon 2 (antisense) oligonucleotide primers， and control PGK transcripts 
A: a 182-bp fragment corresponding to MECTI-MAML2 was detected in MECs (data shown only for case 
3，4，5，7，lOA， 10B， 12)， but not in high-grade MEC (case 19 A， A') and tenWTs (data shown only for case 20)， 
five PAs (data shown only for case30)， and five ACC (data shown only for case35) 
B: The detection of a 189-bp PGK RT-PCR product confirmed the mRNA integrity in al of the samples. 
M; 100 bp DNA ladder 
DISCUSSION 
The diagnosis and classification MECs have until now b巴enbased mainly on histologic 
criteria1， 3，19). Low-grade MEC can resemble benign lesions， ex， mucocele， mucin pools and 
sialometaplasia in the inflammatory or non-inflammatory process in salivary gland. High-
grade MEC may have significant morphologic overlap with squamous cel carcinoma and 
poorly differentiated adenocarcinoma. MECs can also contain lymphoid stroma， in which case 
the differential diagnosis includes Warthin's tumor1. 5. 7) When they contain prominent clear 
cels， they may resemble acinic cel carcinoma， clear cel oncocytoma， clear cell 
adenocarcinoma， epithelial-myoepithelial carcinoma， and myoepithelial carcinoma2. 6). MEC 
may also display an intense sclerosing pattern that obscures its typical morphologic feature4). 
Therefore， t加umo町r一specificgenetic alterations may be pa加rtlcu叶lla凱r匂 a剖t仕ractivetargets in the 
diagnostic setting when hi陪stωopa討thologiたca討1f台巴a討tur巴sand conventional ancila創r}γytechniques are 
insufficient to render an unambiguous diagnosis of MEC. 
Cytogenetic studies of sarcoma have recognized a number of reciprocal translocations that 
correlate with specific tumor types24-26). Molecular cloning of the translocation breakpoints in 
several types of sarcomas has identified fusions between the breakpoint-spanning gene from 
each chromosome4，剖).The resulting genes encode chimeric fusion gene products that appear 
to function in transformation by dysregulating gene transcription or aff巴ctingcelular signal 
transduction pathways24.25). The chimeric RNAs produced from the gene fusions can now be 
detected by RT-PCR， creating specific diagnostic assays for each of these tumors. For some 
gene fusions， molecular detection can be performed using RNA from routine formalin-fixed， 
paraffin-embedded material， which has increased the practical use of this methodology2，27) 
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The chromosoma1 trans1ocation t(l1; 19)(q21 ; p12-13) is the most frequent1y detected 
aberration (30%) in MEC， either as an unique abnorma1ity or together with other chromoso-
ma1 abnorma1ities8). In addition to standard cytogenetics， the mo1ecu1ar cloning of t (1; 
19)(q21; p12-13) in two cel 1ines generated from 1ung and parotid gland MEC has now 
allowed for specific RT-PCR and ISHI5). Martins et a1 demonstrated that these ana1yses were 
sensitive methods for detecting MECT1-MAML2 fusion gene in ME(8) 
To eva1uate the incidence of the MECT1-MAML2 fusion gene， we se1ected a series of 19 
MECs， occurring in nine major and seven minor sa1ivary glands and two 1ungs in the 
RT-PCR ana1ysis， using paraffin-embedded tumor tissue. Our RT-PCR ana1ysis d巴tected
MECT1-MAML2 in 16 (84.5%) of 19 cases， in comparison with the rate 70% of detection that 
Martins reportedI8). Our rate of detection may have been better than that of Martins because 
the MECT1-MAML2 fusion gene amp1ification area that we d巴signedwas short. 
Ten WT  cases were included in this study because a simi1ar trans1ocation t (1; 19)(q13-
21; p12-13)， has been reported in some of these tumorsI3.14). Otherwise， we did not detect 
MECT1-MAML2 expression in 10 WTs using RT-PCR assay， as in the previous reportI8). In 
addition， En1und et a1 reported that one case classified as WT  and exhibiting a t (1; 19) 
expressed the MECT1-MAML2 fusion gene28). WT  and MEC are two distinctive sa1ivary 
gland tumors that do not share clinicopatho1ogica1 features， and their genera1 histogenesis is 
a1so distinct1.19). However， there are some reports of the co-existence of these histo1ogica1 
types in the same gland 1esion5.7)， which might be an exp1anation for the finding of common 
genetic alterations1S). Martins et a1 reported two cases of typica1 MEC with羽TT-1ikeareas， 
and that MECT1-MAML2 expression might be a rare event in WT  samp1es that do not 
contain concomitant evidence for ME(8). The MECT1-MAML2 fusion gene was expressed 
in our two cases with WT-like areas. Both components of MEC and WT-1ike areas were 
included in the two paraffin b10cks in our cases， and it was not possib1e to clear1y determine 
which component was expressed. We detected th巴 MECT1-MAML2fusion gene in both 
sclerosing and clear cel types of恥IJEC.But there has been no report about this fusion gene 
expression in such variant MEC. In addition， MECs occur in the ana1 cana1， esophagus， 
uterus， thymus， thyroid and skin3). Previous reports， as wel1 as our ana1ysis， searched on1y 
for MECT1-MAML2 fusion gene expression in MEC 10cated in sa1ivary glands and 1ungs 8-12. 
15. 18. 29. 30) 
In our three cases of MEC， there was no expression of the MECT1-MAML2 fusion gene 
Histopatho1ogically， two high-grade cases were reminiscent of squamous cel carcinoma. Two 
negative cases reported by Martin et a1 w巴rehigh-grade MECs as wel1 as our r巴su1tI8).But 
our one case is composed of mucous and intermediate cells and we reclassified it as high-
grade MEC. According to previous reports8， 31一円 there are other cytogenetic aberrations in 
MECs， such as rearrangements affecting 6q21-25， 10ss of chromosome Y， and gains of 
chromosomes 2， 3， 5， 6， 18， 20， and X 8.1札却， 30.32，34).Some of these aberrations occurred together 
with t (1; 19) which might indicate they are secondary changes. However， 6q rearrangements 
are not associated with the t (1; 19) trans1ocation. Moreover， 6q r回 rrangementswere found 
in squamous cel carcionomas of sa1ivary gland32，35，約. Some of the MECT1-MAML2 fusion 
gene negative cases in our study without cytogenetic ana1ysis， may have another gen巴
ab巴rration. Further study is needed to exp1ain the pathways of these gene aberrations of 
MECT1-MAML2 fusion transcripts in mucoepidermoid carcinoma (7) 
MEC in comparison with the gene aberrations of other tumors in its differential diagnosis 
In conc1usion， our data confirms the frequent expression of the MECTI-MAML2 fusion 
gene in MEC， supporting the usefulness of RT-PCR using paraffin【embeddedtissue for the 
diagnosis of MEC， especially in histologically challenging cases. 
REFERENCES 
1) Ellis， G.L.， Auclair， P.L. : Tumors of the salivary glands. Atlas of Tumor Pathology. Edited by Rosai ]，
Sobin LH. Washington DC， Armed Forces Institute of Pathology， pp.173-196， 2008目
2) Ellis， G.L.: Clear cel neoplasms in salivary glands: clearly a diagnostic challenge. Ann. Diagn. Patrol. 2 : 
61-78， 1998 
3) Rosai， J.: Rosai and Ackerτnan's surgical pathology. Edinburgh: Mosby， Index 137， 2004. 
4) Fadare， 0.， Hileeto， D.， Gruddin， Y.L.， Mぽ iappan，M.R. : Sclerosing mucoepidermoid carcinoma of the 
parotid gland. Arch.PatroI.Lab.Med. 128・1046-9，2004 
5) Nagao， T.， Sugano， 1.， Ishida， Y.， Tajima， Y.， Furuya， N.， Kondo. Y.， Nagao， K.: Mucoepid巴ロnoidcarci 
noma arising in Warthin's tumour of the parotid gland: r巴portof two cases with histopathological， ultra時
structural and immunohistochemical studies. Histopathology. 33 : 379-386，1998. 
6) Terada， T.， Ikeuchi， S.， Inomoto， C.， Shimamura， K.: Mucoepidermoid carcinoma of the palate composed 
巴xclusivelyof clear cells (clear cel variant).virchows Arch. 445 : 541-543， 2004. 
7) Williamson， J.D.， Simmons， B.H.， el-Naggar， A.， Medeiros， L.J. Mucoepidermoid carcinoma involving 
Warthin tumor. A report of five cases and review of the lit巴rature.Am.].Clin.Pathol. 114 : 564-570， 2000 
8) Mitelman， F.， Johansson， B.， Mertens， F.: Mitelman Database of Chromosom巴 Aberrationsin Cancer.http 
/ / cgap .nci.nih.gov /Chromosomes/Mi telman.2011 
9) Dahlenfors， R.， Wedell， B.， Rundrantz， H.， Mark， J.:Translocation(l1 ; 19)(qI4-21 ; p12) in a parotid mu 
coepidermoid carcinoma of a child. Cancer Genet. Cytog巴net.79・188，1995
10) EI-Naggar， A.K.， Lovell， M.， Ki1lary， A.M.， Clayman， G.L.， Batsakis， J.G. : A muco巴pidermoidcarcinoma 
of minor salivary gland with t(11;19)(q21;pI3.1) as the only karyotypic abnormality. Cancer Genet. 
Cytogenet. 87・29-33，1996 
11) Stenman， G.， Petursdottir， V.， Mellgren， G.， Mark， J.: A child with a t(11;19)(qI4-21;pI2) in a pulmonary 
mucoepidermoid carcinoma. Virchows Arch. 433 : 579-581，1998 
12) Johansson， M.， Mandahl， N.， Johansson， L.， Hambraeus， G.， Mitelman， F.， Heim， S.: Translocation 11;19 
in a mucoepidermoid tumor of th巴 lung.Cancer Genet. Cytogenet. 80 : 85-86. 1995 
13) Bullerdiek， J.， Haubrich， J.， Meyer， K.， Bartnitzke， S.目 Translocationt(11;19)(q21;pI3.1) as the sole chro-
mosome abnormality in a cystadenolymphoma (Warthin's tumor) of the parotid gland. Cancer Genet 
Cytogenet. 35 : 129-32， 1988. 
14) Mark， J.， Dahlenfors， R.， Stenman， G.， Nordquist， A. : A human adenolymphoma showing the chromoso-
mal aberrations del (7)(pI2pI4-15) and t(11;19)(q21;pI2-13). Anticancer Res. 9 : 1565-1566， 1989. 
15) Tonon， G.， Modi， S.，羽TU，L.， Kubo， A.， Coxon， A.B.， Komiya， T.， O'Neil， K.， Stover， K.， EI-Naggar， A.， 
Griffin， J.D.， Kirsch， I.R.， Kaye， F.J. : t(11;19)(q21;pI3) translocation in mucoepiderτnoid carcinoma cre】
ates a novel fusion product that disrupts a Notch signaling pathway. Nat. Genet. 33・208-213，2003. 
16) Co叫cright，M.D.， Canettieri， G.， Screaton， R.， Guzman， E.， Miraglia， L.， Hogenesch， J.B.， Montminy， M. 
TORCs: transducers of regulated CREB activity. Mol. Cell. 12 : 413-23， 2003目
17) Iourgenko， V.， Zhang， W.， Mickanin， C.， Daly， 1.， Jiang， C.， Hexham， J.M.， Orth， A.P.， Miraglia， L.， 
Meltzer， J.， Garza， D.， Chirn， G.W.， McWhinnie， E.， Cohen， D.， Skelton， J.， Terry， R.， Yu， Y.， Bodian， D.， 
Buxton， F.P.， Zhu， J.， Song， C.， Labow， M.A. : Identification of a family of cAMP response element-bind【
(78) T. Kasai， etal. 
ing protein coactivators by g巴nome戸scalefunctional analysis in mammalian cels. Proc. Natl. Acad. Sci. U. 
S. A. 100・12147-12152，2003
18) Martins， C.， Cavaco， B.， Tonon， G.， Kaye， F.J.， Soares， J.， Fonseca， 1.目 Astudy of MECT1-MAML2 in 
mucoepidermoid carcinoma and warthin's tumor of salivary glands. ].Mol.Diagn. 6・205-210，2004 
19) Seifert， G.， Sobin， I.H. : Histological匂rpingof salivary gland tumors. World Health Organization Interna-
tional Histological Classifica tion of Tumors， ed2目 NewYork， Springer-Verlag，1991. 
20) Goode， R.K.， Auclair， P.I.， Ellis， G.1. : Mucoepidermoid carcinoma of the major salivary glands: clinical 
and histopathologic analysis of 234 cases with evaluation of grading criteria. Cancer. 82 : 1217-1224， 1998. 
21) Kasai， T.， Shimajiri， S.， Hashimoto， H. : Detection of SYT-SSX fusion transcripts in both epithelial and 
spindle cel areas of biphasic synovial sarcoma using laser capture microdissection. Mol.Pathol. 53 
107-110， 2000 
22) Tsuji， S.， Hisaoka， M.， Morimitsu， Y.， Hashimoto， H.， Shimajiri， S.， Komiya， S.， Ushijima， M.， Nakamura， 
T.・Detectionof SYT-SSX fusion transcripts in synovial sarcoma by reverse transcription-polymerase 
chain r巴actionusing archival paraffinー巴mbeddedtissues. Am目lPathol目 153 : 1807-1812， 1998. 
23) Majerus， I.J.J.， Oliveira， A.， Inw出・ds，Cヱ， Nascimento， A.G.， Burgard， I.J.， Lloyd， R.V.: Detection of fu-
sion gene transcripts in fresh-frozen and formalin-fixed paraffin四embeddedtissue sections of soft】tissue
sarcomas after laser capt町 emicrodissection and RT-PCR.. Diagn.Mol.Patrol. 12・224-230，2003 
24) Bennicelli， J.I.， B紅 r，F.G. Chromosomal translocations and sarcomas. Curr.Opin. Oncol. 14・412-419，
2002 
25) Borden， E.C.， Baker， I.H.， Bell， R.S.， Bramwell， V.， Demetri， G.D.， Eisenberg， B.I.， Fletcher，C.D.， 
Fletcher， J.A.， Ladanyi， M.， Meltzer， P.， O'Sullivan， B.， P 紅 kinson，D.R.， Piお出s杭t民er悶s鳥， P
S恒g酔er巳， S.， Sundaram， M.， van Oosterom， A.T.， Verweij， J.， Waalen， J.， 羽W匂姐eiおss訊， S
Soft tissue sa紅rc∞omaおs0ぱfadults: state of the translational science. Clin目 Canc巴rRes. 9 : 1941-56， 2003. 
26) Flecher， C.D. Soft tissue tumors:the impact of cytogenetics and molecular genetics. Ver. Dtsch. Ges. 
Pathol. 81 : 318-326， 1997. 
27) de Alava， E.， Ladanyi， M.， Rosai， J.， Gerald， W.1. Detection of chimeric transcripts in desmoplastic 
small round cel tumor and related developmental tumors by reverse transcriptase polymerase chain 
reaction. A specific diagnostic assay. Am.].Pathol. 147 : 1584-91， 1995. 
28) Enlund， F.， Behboudi， A.， Andren， Y.， Oberg， C.， Lendahl， U.， Mark， J.， Stenman， G. : Altered Notch sig-
naling resulting from expression of a W AMTP1-MAML2 gene fusion in mucoepid巴rmoidcarcinomas and 
benign Warthin's tumors. Exp. Cell. Res目 292: 21-28， 2004目
29) EI-Naggar， A.K.， Lovell， M.， Killary， A.M.， Batsakis， J.G.・Genotypiccharacterization of a primary mu-
coepidermoid carcinoma of the parotid gland by cytog巴netic，fluoresc巴ncein situ hybridization， and DNA 
ploidy analysis. Cancer Genet. Cytogenet. 89 : 38-43， 1996 
30) Horsman， D.E.， Berean， K.， Durham， J.S. : Translocation (11;19)(q21;p13.1) in mucoepidermoid carcinoma 
of salivary gland. Cancer Gen巴t目 Cytogenet.80 : 165-166， 1995. 
31) Martins， C.， Fonseca， 1.， Roque， 1.， Pinto， A.E.， Soares， J. : Malignant salivary gland neoplasms: a cytoge-
netic study of 19 cases. Eur. ].Cancer B.Oral Oncol. 32: 128-132， 1996. 
32) Sandros， J.， Mark， J.， Happonen， R.P.， Stenman， G. : Specificity of 6q戸 markersand other recurrent devia-
tions in human malignant salivary gland tumors. Anticancer Res. 8 : 637-643， 1988. 
33) Sandros， J.， Stenman， G.， Mark， J.: Cytogenetic and molecular observations in human and experimental 
salivary gland tumors. Cancer G巴net.Cytogenet. 44・153-167，1990
34) EI-Naggar， A.K.， Lovell， M.， Killary， A.， Batsakis， J.G. : Trisomy 5 as the sole chromosomal abnormality 
in a primary mucoepid巴rmoidcarcinoma of the minor salivary gland. Canc巴rGenet.Cytog巴net.76・96-99，
1994. 
MECTI-MAML2 fusion transcripts in mucoepidermoid carcinoma (79) 
35) Jin， Y.， Mertens， F.， Mandahl， N.， Wennerberg， J.， Dictor， M.， Heim， S.， Mitelman， F.: Tetraploidization 
and progressive loss of 6q in a squamous cel carcinoma of th巴parotidgland.Cancer G巴net.Cytogenet. 79 
: 157-159， 1995. 
36) Mark J， Nordkvist A， Dahlenfors R， Wedell B， Stenman G， Bende M. Complex chromosomal changes in 
a primary squamous carcinoma of the parotid gland. Anticancer Res. 13 : 897-899， 1993. 
